A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.
Member count: 11-50
Founded date: 2020
Investors 2
| Date | Name | Website |
| 18.05.2021 | Logos Capi... | logoscapit... |
| - | OrbiMed | orbimed.co... |